Loss of MLH1/PMS2 protein expression necessitates testing for MLH1 promoter methylation [or BRAF V600E in colorectal cancers (CRCs)] and if negative, germline MMR gene testing. The gene discussed is MLH1; the disease is colorectal cancer.